Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure
Patent
1995-01-24
1996-06-04
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds specifically-identified oligosaccharide structure
4241331, 4241741, 4241811, 4241551, 5303888, 53038885, 5303873, A61K 39395, C07K 1618, C07K 1630
Patent
active
055230857
ABSTRACT:
Monoclonal antibody BR55-2 and fragments thereof having the specificity of monoclonal antibody BR55-2, and variants thereof, are useful in the treatment of small cell lung carcinoma.
REFERENCES:
Thom et al, Biochem J., vol. 168, pp. 187-194 (1977).
Laemmli, Nature, vol. 227, pp. 680-685 (1970).
Wilson et al, Immunofluorescence and Related Staining Techniques, Knapp et al--editors, pp. 215-224 (1978).
Colvin, Diagnotic Immunopathology, Raven Press, New York, pp. 437-452 (1988).
Steplewski, Z. et al., Hybridoma, vol. 9(2):201-210, 1990.
Scholz, D. et al., Cancer Immunol Immunother, 33:153-157, 1991.
Waldmann, T., Science, 252:1657-1662, 21 Jun. 1991.
Osband, M. E. et al., Immunology Today, 11(6):193-195, 1990.
Kannagi, R. et al, Handbook of Exp. Immunol, 4:117.1-117.20, May 30, 1986.
Loibner Hans
Scholz Dieter
Feisee Lila
Loring Susan A.
Sandoz Ltd.
LandOfFree
Monoclonal antibody in destruction of small cell lung carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody in destruction of small cell lung carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody in destruction of small cell lung carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-381726